189 related articles for article (PubMed ID: 288165)
21. Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease.
Kasper DL; Eschenbach DA; Hayes ME; Holmes KK
J Infect Dis; 1978 Jul; 138(1):74-80. PubMed ID: 98597
[TBL] [Abstract][Full Text] [Related]
22. Immunological detection of Bacteroides fragilis in clinical samples.
Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
[TBL] [Abstract][Full Text] [Related]
23. [Demonstration of a species specific determinant of Bacteroides fragilis lipopolysaccharides using monoclonal antibodies].
Schulz TF; Brake BA; Sperzel M; Kofler J; Dierich MP
Wien Klin Wochenschr; 1985 Mar; 97(5):237-9. PubMed ID: 2581371
[TBL] [Abstract][Full Text] [Related]
24. [Demonstration of antibodies to salmonella-R-antigens in sera of patients suffering from salmonelloses (author's transl)].
Schlecht S; Böhlck I; Kuhn M
Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):48-66. PubMed ID: 63195
[TBL] [Abstract][Full Text] [Related]
25. Role of humoral factors in host resistance to the Bacteroides fragilis group.
Bjornson AB
Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
[TBL] [Abstract][Full Text] [Related]
26. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.
Bamba T; Matsuda H; Endo M; Fujiyama Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():45-7. PubMed ID: 8563888
[TBL] [Abstract][Full Text] [Related]
27. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
Kasper DL
J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
[TBL] [Abstract][Full Text] [Related]
28. Capsular and 'O' serotype determinants of bacteroides fragilis.
Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
Infection; 1982; 10(6):333-7. PubMed ID: 6185437
[TBL] [Abstract][Full Text] [Related]
29. Identification of Bacteroides fragilis by indirect immunofluorescence.
Weintraub A; Lindberg AA; Nord CE
Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
[TBL] [Abstract][Full Text] [Related]
30. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
[TBL] [Abstract][Full Text] [Related]
31. Detection of specific IgG antibody in sera from patients infected with Bacteroides fragilis by enzyme-linked immunosorbent assay.
Rissing JP; Buxton TB; Edmondson HT
J Infect Dis; 1979 Dec; 140(6):994-8. PubMed ID: 396340
[TBL] [Abstract][Full Text] [Related]
32. [Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans].
Chmelar D; Vrtný J
Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):97-102. PubMed ID: 20640988
[TBL] [Abstract][Full Text] [Related]
33. Assessment of lipopolysaccharide and outer membrane of Bacteroides fragilis by an antibody-inhibition enzyme-linked immunosorbent assay in physiologic fluids and infected animals.
Rissing JP; Buxton TB; Harris R; Moore W
J Lab Clin Med; 1981 Nov; 98(5):784-94. PubMed ID: 7299246
[TBL] [Abstract][Full Text] [Related]
34. Detection of specific bacterial antigen in urine of patients infected with Bacteroides fragilis.
Rissing JP; Buxton TB; Harris RW; Shockley RK
J Infect Dis; 1984 Jun; 149(6):929-34. PubMed ID: 6736683
[TBL] [Abstract][Full Text] [Related]
35. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
[TBL] [Abstract][Full Text] [Related]
36. Detection of Bacteroides infection by counter immunoelectrophoresis test.
Lalitha MK; Mathai E; Elias L; Anandi V; Kalpana CR
Indian J Med Res; 1991 May; 93():171-3. PubMed ID: 1937595
[TBL] [Abstract][Full Text] [Related]
37. The bactericidal action of human serum on Bacteroides species.
Rotimi VO; Eke PI
J Med Microbiol; 1984 Dec; 18(3):355-63. PubMed ID: 6502677
[TBL] [Abstract][Full Text] [Related]
38. [Demonstration of antibodies against Bacteroides fragilis in children using ELISA].
Pietsch M; Dierich MP
Wien Klin Wochenschr; 1985 Oct; 97(19):754-5. PubMed ID: 4060733
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
[TBL] [Abstract][Full Text] [Related]
40. Virulence factors in Bacteroides fragilis group.
Jotwani R; Gupta U
Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
